# Topical ENS-002 for Atopic Dermatitis in Adults

> **NCT06469385** · PHASE1 · TERMINATED · sponsor: **Concerto Biosciences** · enrollment: 9 (actual)

## Conditions studied

- Atopic Dermatitis
- Atopic Dermatitis Eczema

## Interventions

- **BIOLOGICAL:** ENS-002

## Key facts

- **NCT ID:** NCT06469385
- **Lead sponsor:** Concerto Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-09-18
- **Primary completion:** 2025-08-04
- **Final completion:** 2025-08-04
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Planned safety, efficacy and proof of mechanism obtained
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06469385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06469385, "Topical ENS-002 for Atopic Dermatitis in Adults". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06469385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*